OraSure Expects Growth in 2021 with New COVID-19 Tests

As OraSure Technologies, Inc. quickly pivoted to address the COVID-19 pandemic, it experienced a 11% growth in sales in 2020, $50 million of which was in COVID-19-related testing equipment. “It was easy to pivot to COVID-19 because we have expertise in that area of global pandemics,” said Stephen Tang, president and CEO. The company even had one of its products, the OraSure OMNIgene collecting devices named as one of Time Magazine’s Best 100 Inventions of 2020. Via Lehigh Valley Business